HLNE
Hamilton Lane Incorporated
HLNE has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
HLNE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
HLNE's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like HLNE.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
HLNE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $93.88 | — |
| Current | 14x | $93.88 | — |
| Cheap | 17x | $116 | +24% |
| Fair | 27x | $179 | +91% |
| Expensive | 37x | $249 | +165% |
Historical ranges are pointers, not guarantees.
HLNE has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
HLNE Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
HLNE has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
HLNE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.30 | +8.4% |
| Q3 2026 | $6.74 | +22% |
| Q2 2026 | $6.56 | +26% |
| Q1 2026 | $5.91 | +9.6% |
| Q4 2025 | $5.57 | +1.6% |
| Q4 2021 | $4.59 | +89% |
| Q3 2021 | $4.15 | +115% |
| Q2 2021 | $3.40 | +86% |
| Q1 2021 | $2.73 | +28% |
HLNE has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
HLNE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $204.4M | +7.1% |
| Q2 2026 | $275.3M | +56% |
| Q1 2026 | $193.6M | -2.2% |
| Q4 2025 | $198.6M | +18% |
| Q3 2025 | $190.9M | +27% |
| Q2 2025 | $176M | -11% |
| Q1 2025 | $198M | +18% |
| Q2 2024 | $196.7M | +57% |
HLNE's revenue is growing: $204M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 87% | +46 points |
| Q2 2026 | 46% | +2.2 points |
| Q1 2026 | 42% | 0 points |
| Q4 2025 | 43% | -1.7 points |
| Q3 2025 | 42% | -3 points |
| Q2 2025 | 44% | -1.8 points |
| Q1 2025 | 42% | -2.5 points |
| Q4 2024 | 45% | N/A |
HLNE has the edge over JPM on profitability, with a higher operating margin.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
HLNE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.8M | -81% |
| Q2 2026 | $98.9M | -22% |
| Q1 2026 | $101.2M | +182% |
| Q4 2025 | $72.4M | +23% |
| Q3 2025 | $120.1M | +3.7% |
| Q2 2025 | $127.6M | +63% |
| Q1 2025 | $35.8M | +78% |
| Q2 2024 | $78.2M | 0% |
HLNE has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
HLNE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +1.3M shares |
| 1 year | +2.3% | +1.3M shares |
| 3 years | +3.8% | +2M shares |
| 5 years | +60% | +21M shares |
| Available history | +88% | +26.1M shares |
HLNE has 56M diluted shares, up 2.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $50.6M |
| Q1 2026 | $23.2M |
| Q4 2025 | $595,000 |
| Q3 2025 | $835,000 |
| Q2 2025 | $7,000 |
| Q1 2025 | $252.9M |
| Q4 2024 | $72,000 |
| Q3 2024 | $391,000 |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over HLNE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
HLNE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 0.0x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | 0.1x | Very low |
HLNE has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
HLNE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 31.1 | Neutral |
HLNE's weekly RSI is 51 (neutral) and its Stochastic is 31 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
HLNE PE vs Financial Services Sector
| Metric | HLNE | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 7% above |
| PE % | 4 | 63 | 59 pts below |
HLNE has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
HLNE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $86.3 | 8.8% above |
| 20 week MA | $90.6 | 3.6% above |
| 50 week MA | $101.7 | 7.7% below |
| 100 week MA | $123.8 | 24% below |
| 200 week MA | $117.2 | 20% below |
HLNE has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 20% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over HLNE on trend strength, trading above more of its moving averages.
HLNE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.2 | $78.7 | +29% |
| 2021 | $78.7 | $103.7 | +32% |
| 2022 | $103.7 | $65.5 | -37% |
| 2023 | $65.5 | $113.4 | +73% |
| 2024 | $113.4 | $151.6 | +34% |
| 2025 | $151.6 | $138.5 | -8.6% |
| 2026 YTD | $138.5 | $93.9 | -32% |
HLNE is down 32% so far in 2026, after finishing higher in four of the previous six years.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over HLNE on returns for 2026, with the stronger performance.